Tenet Healthcare (THC) | Financial Analysis & Statements
Tenet Healthcare Corporation Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
5.5B
Gross Profit
4.5B
81.73%
Operating Income
869.0M
15.72%
Net Income
644.0M
11.65%
Balance Sheet Metrics
Total Assets
29.7B
Total Liabilities
20.7B
Shareholders Equity
9.0B
Debt to Equity
2.31
Cash Flow Metrics
Operating Cash Flow
750.0M
Free Cash Flow
367.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Tenet Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 21.3B | 20.7B | 20.5B | 19.2B | 19.5B |
| Cost of Goods Sold | 3.8B | 3.6B | 3.6B | 3.3B | 3.3B |
| Gross Profit | 17.5B | 17.0B | 17.0B | 15.9B | 16.2B |
| Gross Margin % | 82.3% | 82.4% | 82.5% | 82.9% | 82.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 8.7B | 8.8B | 9.1B | 8.8B | 8.9B |
| Other Operating Expenses | 4.5B | 4.5B | 4.5B | 3.8B | 4.0B |
| Total Operating Expenses | 13.2B | 13.3B | 13.6B | 12.6B | 12.9B |
| Operating Income | 3.4B | 2.9B | 2.4B | 2.4B | 2.4B |
| Operating Margin % | 16.1% | 14.1% | 11.9% | 12.6% | 12.4% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 821.0M | 826.0M | 901.0M | 890.0M | 923.0M |
| Other Non-Operating Income | 182.0M | 3.2B | 75.0M | -178.0M | 402.0M |
| Pre-tax Income | 2.8B | 5.2B | 1.6B | 1.3B | 1.9B |
| Income Tax | 433.0M | 1.2B | 306.0M | 344.0M | 411.0M |
| Effective Tax Rate % | 15.5% | 22.6% | 18.9% | 25.6% | 21.8% |
| Net Income | 1.4B | 4.1B | 1.3B | 1.0B | 1.5B |
| Net Margin % | 6.6% | 19.7% | 6.4% | 5.2% | 7.6% |
| Key Metrics | |||||
| EBITDA | 4.7B | 4.1B | 3.6B | 3.5B | 3.5B |
| EPS (Basic) | $15.61 | $33.02 | $6.01 | $3.84 | $8.55 |
| EPS (Diluted) | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 |
| Basic Shares Outstanding | 90150000 | 96904000 | 101639000 | 106929000 | 106833000 |
| Diluted Shares Outstanding | 90150000 | 96904000 | 101639000 | 106929000 | 106833000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Tenet Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.9B | 3.0B | 1.2B | 858.0M | 2.4B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 2.6B | 2.5B | 2.9B | 2.9B | 2.8B |
| Inventory | 348.0M | 346.0M | 411.0M | 405.0M | 384.0M |
| Other Current Assets | 278.0M | 313.0M | 369.0M | 231.0M | 158.0M |
| Total Current Assets | 7.8B | 7.7B | 7.2B | 6.0B | 7.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 6.7B | 6.0B | 6.2B | 6.3B | 5.9B |
| Goodwill | 23.7B | 22.8B | 22.0B | 21.7B | 20.0B |
| Intangible Assets | 1.3B | 1.4B | 1.4B | 1.4B | 1.5B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 138.0M | 497.0M | 541.0M | 352.0M | 445.0M |
| Total Non-Current Assets | 21.8B | 21.3B | 21.1B | 21.2B | 20.5B |
| Total Assets | 29.7B | 28.9B | 28.3B | 27.2B | 27.6B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.4B | 1.3B | 1.4B | 1.5B | 1.3B |
| Short-term Debt | 79.0M | 92.0M | 120.0M | 145.0M | 135.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.8B | 1.6B | 1.8B | 1.6B | 1.4B |
| Total Current Liabilities | 4.5B | 4.3B | 4.8B | 4.5B | 5.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 13.1B | 13.1B | 14.9B | 14.9B | 15.5B |
| Deferred Tax Liabilities | 240.0M | 227.0M | 326.0M | 217.0M | 36.0M |
| Other Non-Current Liabilities | 1.7B | 1.6B | 1.7B | 1.8B | 1.4B |
| Total Non-Current Liabilities | 16.2B | 16.1B | 18.0B | 18.1B | 18.2B |
| Total Liabilities | 20.7B | 20.4B | 22.8B | 22.5B | 23.3B |
| Equity | |||||
| Common Stock | 8.0M | 8.0M | 8.0M | 8.0M | 8.0M |
| Retained Earnings | 4.4B | 3.0B | -192.0M | -803.0M | -1.2B |
| Treasury Stock | - | 3.5B | 2.9B | 2.7B | 2.4B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 9.0B | 8.5B | 5.5B | 4.6B | 4.3B |
| Key Metrics | |||||
| Total Debt | 13.2B | 13.2B | 15.0B | 15.1B | 15.6B |
| Working Capital | 3.4B | 3.4B | 2.4B | 1.5B | 2.0B |
Balance Sheet Composition
Tenet Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.4B | 4.1B | 1.3B | 1.0B | 1.5B |
| Depreciation & Amortization | 863.0M | 818.0M | 870.0M | 841.0M | 855.0M |
| Stock-Based Compensation | 104.0M | 67.0M | 66.0M | 56.0M | 56.0M |
| Working Capital Changes | 140.0M | 136.0M | 71.0M | -1.1B | -737.0M |
| Operating Cash Flow | 3.5B | 5.0B | 2.4B | 997.0M | 1.9B |
| Investing Activities | |||||
| Capital Expenditures | -972.0M | 4.0B | -680.0M | -552.0M | 590.0M |
| Acquisitions | -308.0M | -571.0M | -224.0M | -234.0M | -1.2B |
| Investment Purchases | -90.0M | -94.0M | -104.0M | -92.0M | -108.0M |
| Investment Sales | 93.0M | 63.0M | 50.0M | 76.0M | 31.0M |
| Investing Cash Flow | -1.3B | 3.4B | -969.0M | -808.0M | -714.0M |
| Financing Activities | |||||
| Share Repurchases | -1.4B | -672.0M | -200.0M | -250.0M | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 2.3B | 23.0M | 1.4B | 2.0B | 2.9B |
| Debt Repayment | -2.4B | -2.2B | -1.5B | -2.9B | -3.2B |
| Financing Cash Flow | -2.4B | -3.7B | -1.0B | -1.8B | -936.0M |
| Free Cash Flow | 2.5B | 1.1B | 1.6B | 321.0M | 910.0M |
| Net Change in Cash | -164.0M | 4.7B | 381.0M | -1.6B | 237.0M |
Cash Flow Trend
Tenet Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.17
Forward P/E
10.76
Price to Book
3.88
Price to Sales
0.77
PEG Ratio
10.76
Profitability Ratios
Profit Margin
6.60%
Operating Margin
17.46%
Return on Equity
27.02%
Return on Assets
8.04%
Financial Health
Current Ratio
1.76
Debt to Equity
160.79
Beta
1.50
Per Share Data
EPS (TTM)
$15.48
Book Value per Share
$48.53
Revenue per Share
$236.38
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| THC | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Universal Health | 11.1B | 7.84 | 1.52 | 21.33% | 8.57% | 69.73 |
| Ensign Group | 11.1B | 32.78 | 4.95 | 16.90% | 6.80% | 98.70 |
| Encompass Health | 10.2B | 18.52 | 4.21 | 24.82% | 9.54% | 82.85 |
| DaVita | 10.0B | 16.32 | 9.13 | 64.85% | 5.47% | 1,111.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.






